1. Virapen J. Side Effects: death. College Station: Virtualbookworm.com Publishing; 2010.

2. Angell M. The Truth about the Drug Companies: how they deceive us and what to do about it. New York: Random House; 2004.

3. Abramson J. Overdsed America: the broken promise of American medicine. New York: HarperCollins; 2004.

4. Wilmshurst P. Academia and industry. Lancet. 2000; 356: 338–44.

5. Steinman M.A., Bero L.A., Chren M.M., et al. Narrative review: the promotion of gabapentin: an analysis of internal industry documents. Ann Intern Med. 2006; 145: 284–93.

6. Braithwaite J. Corporate Crime in the Pharmaceutical Industry. London: Routledge & Kegan Paul; 1984.

17. Transparency International. Global Corruption Report 2006. Available online at: www. transparency.org/publications/gcr (accessed 8 February 2008).

18. House of Commons Health Committee. The Infl uence of the Pharmaceutical Industry. Fourth Report of Session 2004–05. 2005. Available online at: www.publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/42.pdf (accessed 26 April 2005).

19. Chren M.M., Landefeld C.S. Physicians’ behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. JAMA. 1994; 271: 684–9.

10. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA 2000; 283: 373–80.

11. Grill M. Kranke Geschäfte: wie die Pharmaindustrie uns manipuliert. Hamburg: Rowohlt Verlag; 2007.

12. Mundy A. Dispensing with the Truth. New York: St. Martin’s Press; 2001.

13. Avorn J. Powerful Medicines: the benefits, risks, and costs of prescription drugs. New York: Vintage Books; 2005.

14. Kassirer J.P. On the Take: how medicine’s complicity with big business can endanger your health. Oxford: Oxford University Press; 2005.

15. Gale E.A. Conflicts of interest in guideline panel members. BMJ. 2011; 343: d5728.

16. Boseley S. Drug firms using backdoor tactics to boost sales, report reveals. The Guardian. 2011 Sept 23.

17. Lenzer J. Whistleblower removed from job for talking to the press. BMJ. 2004; 328: 1153.

18. Elliott C. The drug pushers. The Atlantic Monthly. 2006 April.

19. Palo J. Why did my colleagues turn to crime? BMJ. 2004; 328: 1083.

20. Applegate W.B., Furberg C.D., Byington R.P., et al. The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). JAMA. 1997; 277: 297.

21. Harris G. As doctors write prescriptions, drug company writes a check. New York Times. 2004 June 27.

22. Elkjær B., Rebouh D., Jensen J., et al. [See if your doctor is in industry’s pocket]. Ekstra Bladet. 2010 June 24.

23. Editorial. [The greedy doctors]. Ekstra Bladet. 2010 June 24.